Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 39% ± 16% | |
| peripheral blood | 16 studies | 29% ± 11% | |
| intestine | 11 studies | 41% ± 18% | |
| kidney | 9 studies | 36% ± 14% | |
| brain | 8 studies | 32% ± 13% | |
| eye | 7 studies | 23% ± 9% | |
| bone marrow | 6 studies | 33% ± 13% | |
| liver | 6 studies | 34% ± 14% | |
| pancreas | 5 studies | 42% ± 20% | |
| lymph node | 5 studies | 35% ± 15% | |
| placenta | 4 studies | 63% ± 29% | |
| uterus | 4 studies | 52% ± 19% | |
| prostate | 4 studies | 34% ± 10% | |
| breast | 4 studies | 35% ± 3% | |
| adrenal gland | 3 studies | 36% ± 8% | |
| skin | 3 studies | 27% ± 8% | |
| thymus | 3 studies | 42% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 5343.97 | 359 / 359 | 99% | 157.23 | 284 / 286 |
| esophagus | 100% | 4111.87 | 1442 / 1445 | 99% | 116.77 | 182 / 183 |
| lung | 100% | 6652.93 | 577 / 578 | 99% | 202.45 | 1147 / 1155 |
| pancreas | 100% | 7876.18 | 328 / 328 | 99% | 117.66 | 176 / 178 |
| intestine | 100% | 5052.04 | 965 / 966 | 99% | 173.52 | 520 / 527 |
| ovary | 100% | 5000.62 | 180 / 180 | 98% | 145.70 | 423 / 430 |
| breast | 100% | 5025.78 | 459 / 459 | 98% | 149.55 | 1098 / 1118 |
| prostate | 100% | 3613.89 | 244 / 245 | 97% | 148.00 | 487 / 502 |
| skin | 100% | 9546.81 | 1805 / 1809 | 96% | 175.11 | 455 / 472 |
| uterus | 100% | 5251.32 | 170 / 170 | 96% | 164.57 | 441 / 459 |
| bladder | 100% | 5071.29 | 21 / 21 | 95% | 156.55 | 480 / 504 |
| thymus | 100% | 10016.23 | 653 / 653 | 95% | 151.07 | 572 / 605 |
| kidney | 100% | 5239.74 | 89 / 89 | 89% | 112.45 | 804 / 901 |
| liver | 95% | 6246.46 | 214 / 226 | 94% | 119.91 | 383 / 406 |
| brain | 86% | 1843.05 | 2280 / 2642 | 98% | 89.31 | 689 / 705 |
| adrenal gland | 100% | 6243.79 | 258 / 258 | 73% | 55.04 | 169 / 230 |
| adipose | 100% | 5689.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6005.26 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5568.31 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 124.65 | 44 / 45 |
| muscle | 97% | 2172.15 | 780 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 123.20 | 27 / 29 |
| heart | 92% | 4230.84 | 796 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 68.34 | 72 / 80 |
| peripheral blood | 87% | 4674.72 | 810 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006457 | Biological process | protein folding |
| GO_0034976 | Biological process | response to endoplasmic reticulum stress |
| GO_0042470 | Cellular component | melanosome |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0034663 | Cellular component | endoplasmic reticulum chaperone complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0015035 | Molecular function | protein-disulfide reductase activity |
| GO_0003756 | Molecular function | protein disulfide isomerase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PDIA6 |
| Protein name | Protein disulfide isomerase family A member 6 Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7) |
| Synonyms | P5 ERP5 TXNDC7 |
| Description | FUNCTION: May function as a chaperone that inhibits aggregation of misfolded proteins . Negatively regulates the unfolded protein response (UPR) through binding to UPR sensors such as ERN1, which in turn inactivates ERN1 signaling . May also regulate the UPR via the EIF2AK3 UPR sensor . Plays a role in platelet aggregation and activation by agonists such as convulxin, collagen and thrombin . . |
| Accessions | ENST00000272227.8 [Q15084-1] ENST00000540494.5 [Q15084-3] ENST00000404371.6 [Q15084-2] ENST00000381611.8 [Q15084-4] ENST00000617249.4 [Q15084-2] ENST00000404824.2 [Q15084-5] ENST00000458536.1 C9JNG5 Q15084 |